Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571)

Leukemia and Lymphoma

Volumn 45, Issue 4, 2004, Pages 695-698

  Leis, Jose F ^a   Stepan, Daniel E ^a   Curtin, Peter T ^a   Ford, John M ^b   Peng, Bin ^b   Schubach, Susan ^a   Druker, Brian J ^a   Maziarz, Richard T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

ALL; CML blast crisis; CNS leukemia; Imatinib

Indexed keywords

BCR ABL PROTEIN; IMATINIB; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLAST CELL CRISIS; BLOOD BRAIN BARRIER; CANCER RECURRENCE; CENTRAL NERVOUS SYSTEM METASTASIS; CEREBROSPINAL FLUID ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG PENETRATION; DRUG TRANSPORT; FEMALE; HUMAN; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MULTICENTER STUDY; PHENOTYPE; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL;

ADULT; BLAST CRISIS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; RECURRENCE; REMISSION INDUCTION; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 1342330066     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001625728     Document Type: Article

References (16)

1. Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S.P., Kurzrock, R. and Kantarjian, H.M. (1999) "The biology of chronic myeloid leukemia", N. Engl. J. Med., 341, 164-172.
2. Sawyers, C.L. (1999) "Chronic myeloid leukemia", N. Engl. J. Med., 340, 1330-1340.
3. Copelan, E.A. and McGuire, E.A. (1995) "The biology and treatment of acute lymphoblastic leukemia in adults", Blood, 85, 1151-1168.
4. Berg, S.L., Steuber, P. and Poplack, D.G. (2000) Clinical manifestations of acute lymphoblastic leukemia. In Hematology: basic principles and practice (3rd edn). edited by R. Hoffman, E.J. Benz, S.J. Shattil, B. Furie, H.J. Cohen, L.E. Silberstein and P.B. McGlave. Pp. 1070-1078. Philadelphia, PA: Churchill Livingstone.
5. Abbot, N.J. and Romero, I.A. (1996) "Transporting therapeutics across the blood-brain barrier", Mol. Med. Today, 2, 106-113.
6. Kroll, R.A. and Neuwelt, E.A. (1998) "Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means", Neurosurgery, 42, 1083-1100.
7. Cornford, E.M. and Hyman, S. (1999) "Blood-brain barrier permeability to small and large molecules", Adv. Drug Del. Rev., 36, 145-163.
8. Druker, B.J., Tamura, S., Buchdunger, E., et al. (1996) "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells", Nat. Med., 2, 561-566.
9. Deininger, M.W., Goldman, J.M., Lydon, N. and Melo, J.V. (1997) "The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells", Blood, 90, 3691-3698.
10. Druker, B.J., Sawyers, C.L., Kantarjian, H., et al. (2001) "Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome", N. Engl. J. Med., 344, 1038-1042.
11. Sawyers, C.L., Hochhaus, A., Feldman, E., Goldman, J., Miller, C., Ottmann, O., et al. (2002) "Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study", Blood, 99, 3530-3539.
12. Ottmann, O.G., Druker, B.J., Sawyers, C.L., Goldman, J.M., Reiffers, J., Silver, R.T., et al. (2002) "A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias", Blood, 100, 1965-1971.
13. Druker, B.J., Talpaz, M., Resta, D.J., et al. (2001) "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia" N. Engl. J. Med., 344, 1031-1037.
14. Petzer, A.L., Gunsilius, E., Hayes, M., Stockhammer, G., Duba, H.C., Schneller, F., et al. (2002) "Low concentrations of STI571 in the cerebrospinal fluid: a case report", Br. J. Haematol., 117, 623-625.
15. Takayama, N., Sato, N., O'Brien, S.G., Ikeda, Y. and Okamoto, S. (2002) "Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid", Br. J. Haematol., 119, 106-108.
16. Mahon, F.X., Deininger, M.W., Schultheis, B., et al. (2000) "Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance", Blood, 96, 1070-1079.